Hospira Vinorelbine Tartrate 50 mg/5 mL Injection vial

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

vinorelbine tartrate, Quantity: 13.85 mg/mL

Boleh didapati daripada:

Hospira Australia Pty Ltd

INN (Nama Antarabangsa):

Vinorelbine tartrate

Borang farmaseutikal:

Injection

Komposisi:

Excipient Ingredients: water for injections

Laluan pentadbiran:

Intravenous

Unit dalam pakej:

1 X 5 mL

Kelas:

Medicine Listed (Export Only)

Jenis preskripsi:

Not scheduled. Not considered by committee

Tanda-tanda terapeutik:

Vinorelbine is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced nonsmall cell lung cancer (NSCLC). In patients with Stage IV NSCLC, Vinorelbine is indicated as a single agent or in combination with cisplatin. In Stage III NSCLC, Vinorelbine is indicated in combination with cisplatin.

Ringkasan produk:

Visual Identification: A clear, colourless to pale yellow solution & free from visible particulates; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Status kebenaran:

Licence status A

Tarikh kebenaran:

2008-05-21